Publications

Does Semaglutide Reduce Kidney Disease Events on Top of Sglt2 Inhibitors in Patients with Ckd and T2D?

AuthID
P-01B-KXH

Author(s)

FERREIRA, JP

MENDONÇA, L

NEVES, JS

Document Type

Article

Year published

2024

Published

in Journal of Cardiac Failure, ISSN: 1071-9164

Volume: 30, Issue: 9, Pages: 1181-1182

Indexing

Crossref^®2

Google Scholar^®

Publication Identifiers

DOI: 10.1016/j.cardfail.2024.05.006

Source Identifiers

ISSN: 1071-9164

Export Publication Metadata

Marked List

Add to Marked List

Citations

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference

No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Full Text

Full Text @ sfx.b-on.pt

Does Semaglutide Reduce Kidney Disease Events on Top of Sglt2 Inhibitors in Patients with Ckd and T2D?

Useful Links

Get Help

Federated Authentication (Click on the image)

Does Semaglutide Reduce Kidney Disease Events on Top of Sglt2 Inhibitors in Patients with Ckd and T2D?

Useful Links

Get Help